{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-001258","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2026-07-30T16:02:58+00:00","discovered_at":"2026-07-30T16:04:00.603644+00:00","generated_at":"2026-07-30T16:04:06.860837+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lexaria Bioscience announces 1-for-15 reverse stock split effective Aug 3, 2026 to regain Nasdaq compliance","bullets":["Reverse split ratio 1-for-15; effective 12:01 a.m. ET on August 3, 2026.","Outstanding shares reduced from ~24.8M to ~1.65M; authorized shares cut from 220M to 14.7M.","Primary goal: regain Nasdaq minimum $1.00 bid price compliance under Listing Rule 5550(a)(2).","No fractional shares issued; fractional shares rounded up to whole shares.","Stock symbol LEXX unchanged; new CUSIP 52886N604."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-001258","json":"https://secwatch.observer/filing/0001640334-26-001258.json","markdown":"https://secwatch.observer/filing/0001640334-26-001258.md","text":"https://secwatch.observer/filing/0001640334-26-001258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033426001258/0001640334-26-001258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033426001258/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T16:04:06.860837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}